JP2009541340A5 - - Google Patents

Download PDF

Info

Publication number
JP2009541340A5
JP2009541340A5 JP2009516666A JP2009516666A JP2009541340A5 JP 2009541340 A5 JP2009541340 A5 JP 2009541340A5 JP 2009516666 A JP2009516666 A JP 2009516666A JP 2009516666 A JP2009516666 A JP 2009516666A JP 2009541340 A5 JP2009541340 A5 JP 2009541340A5
Authority
JP
Japan
Prior art keywords
carbon atoms
compound according
compound
alkyl
prodrug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2009516666A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009541340A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/071515 external-priority patent/WO2007149829A2/en
Publication of JP2009541340A publication Critical patent/JP2009541340A/ja
Publication of JP2009541340A5 publication Critical patent/JP2009541340A5/ja
Ceased legal-status Critical Current

Links

JP2009516666A 2006-06-20 2007-06-19 治療用化合物 Ceased JP2009541340A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80528506P 2006-06-20 2006-06-20
PCT/US2007/071515 WO2007149829A2 (en) 2006-06-20 2007-06-19 Therapeutic compounds

Publications (2)

Publication Number Publication Date
JP2009541340A JP2009541340A (ja) 2009-11-26
JP2009541340A5 true JP2009541340A5 (OSRAM) 2010-08-05

Family

ID=38728727

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009516666A Ceased JP2009541340A (ja) 2006-06-20 2007-06-19 治療用化合物

Country Status (7)

Country Link
US (3) US7429669B2 (OSRAM)
EP (1) EP2046714B1 (OSRAM)
JP (1) JP2009541340A (OSRAM)
AU (1) AU2007261034B2 (OSRAM)
BR (1) BRPI0713587A2 (OSRAM)
CA (1) CA2657967A1 (OSRAM)
WO (1) WO2007149829A2 (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1846354T3 (da) * 2005-01-14 2010-08-16 Allergan Inc Substituterede cyclopentaner eller cyclopentanoner til behandling af okular hypertensive tilstande
US7429669B2 (en) * 2006-06-20 2008-09-30 Allergan, Inc. Therapeutic compounds
AU2007272683B2 (en) * 2006-07-10 2012-08-23 Allergan, Inc. Substituted cyclopentane derivatives as therapeutic agents
ES2549863T3 (es) * 2006-07-11 2015-11-02 Allergan, Inc. Derivados de ciclopentano como agentes antiglaucoma
EP2114913B1 (en) * 2007-01-22 2011-06-01 Allergan, Inc. Thiophene derivatives useful as ocular hypotensive agents
ES2358558T3 (es) * 2007-02-01 2011-05-11 Allergan, Inc. Derivados de tiofeno como medicamentos para el tratamiento de la hipertensión ocular.
RU2010103149A (ru) 2007-07-03 2011-08-10 Аллерган, Инк. (Us) Терапевтические замещенные циклопентаны для уменьшения внутриглазного давления
US7947732B2 (en) * 2007-07-13 2011-05-24 Allergan, Inc. Therapeutic substituted chlorocyclopentanols
US7662850B2 (en) * 2007-07-13 2010-02-16 Allergan, Inc. Therapeutic substituted chlorocyclopentanols
WO2009111322A1 (en) * 2008-03-04 2009-09-11 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US8487091B2 (en) * 2008-03-04 2013-07-16 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US7964596B2 (en) * 2008-03-07 2011-06-21 Allergan, Inc. Therapeutic compounds
CA2722312C (en) * 2008-04-24 2016-08-09 Allergan, Inc. Thiophene derivatives useful as ocular hypotensive agents
WO2009132093A2 (en) * 2008-04-24 2009-10-29 Allergan, Inc. Substituted arylcyclopentenes as therapeutic agents
WO2009137411A1 (en) * 2008-05-09 2009-11-12 Allergan, Inc. Therapeutic compounds
EP2291346A2 (en) * 2008-05-15 2011-03-09 Allergan, Inc. Therapeutic substituted cyclopentanes
CA2724467C (en) * 2008-05-20 2016-09-13 Allergan, Inc. Therapeutic lactams
US8541603B2 (en) * 2008-05-27 2013-09-24 Allergan, Inc. Substituted cyclopentanes or cyclopentanones as therapeutic agents
JP5652397B2 (ja) 2009-07-28 2015-01-14 小野薬品工業株式会社 二環式化合物およびその医薬用途
JP5835236B2 (ja) 2011-01-27 2015-12-24 小野薬品工業株式会社 二環式化合物およびその医薬用途
WO2012102355A1 (ja) 2011-01-27 2012-08-02 小野薬品工業株式会社 二環式化合物およびその医薬用途
US9315486B2 (en) 2013-10-29 2016-04-19 Allergan, Inc. Therapeutic cyclopentanols, compositions thereof, and methods for use thereof
US9890146B2 (en) 2014-02-27 2018-02-13 Ono Pharmaceutical Co., Ltd. Compound having selective EP2 agonist activity
DK3152188T3 (en) 2014-06-06 2019-04-29 Allergan Inc UNKNOWN EP4 AGONISTS AS THERAPEUTIC RELATIONS
EP3327018B1 (en) 2015-07-23 2020-11-25 ONO Pharmaceutical Co., Ltd. 2-(octahydrocyclopenta[b]pyran-2-yl)1,3-thiazole-4-carboxylic acid derivatives and related compounds as ep2 agonists with intraocular pressure lowering activity
ES2890989T3 (es) 2016-06-30 2022-01-25 Ono Pharmaceutical Co Método para producir un compuesto bicíclico

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980700A (en) 1971-10-07 1976-09-14 G. D. Searle & Co. Prostaglandin intermediates and optically active isomers thereof
ZA733967B (en) * 1972-06-15 1974-11-27 Erba Carlo Spa 9-desoxy-prosta-5,9(10),13-trienoic acid derivatives and process for their preparation
DE2256537A1 (de) 1972-11-17 1974-10-10 Merck Patent Gmbh Neue sulfide
US4073799A (en) 1975-02-27 1978-02-14 (Zaidanhojin) Sagami Chemical Research Center Process for producing 3-formylcyclopentanone derivatives
JPS51110557A (en) 1975-03-26 1976-09-30 Sagami Chem Res Rakutonsurufuidono seizohoho
US4094886A (en) 1976-03-01 1978-06-13 (Zaidanhojin) Sagami Chemical Research Center Process for producing allyl alcohol derivatives useful in prostaglandin synthesis
DE3543991A1 (de) * 1985-12-10 1987-06-11 Schering Ag Verfahren zur herstellung von 9(beta)-chlor-prostaglandinen
JP2943306B2 (ja) 1990-10-12 1999-08-30 住友化学工業株式会社 シクロペンタンアルデヒド類およびその製造法
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5688819A (en) 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
AU693698B2 (en) * 1995-05-18 1998-07-02 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylakenyl derivatives as therapeutic agents for the treatment of ocular hypertension
WO1998058911A2 (en) 1997-06-23 1998-12-30 Pfizer Inc. Prostaglandin agonists
EP1108426A3 (en) 1999-12-02 2002-10-02 Pfizer Products Inc. Use of prostaglandin agonists to treat erectile dysfunction or impotence
JP4149153B2 (ja) 2001-09-28 2008-09-10 富士フイルム株式会社 ポジ型レジスト組成物
DK1846354T3 (da) 2005-01-14 2010-08-16 Allergan Inc Substituterede cyclopentaner eller cyclopentanoner til behandling af okular hypertensive tilstande
US7323591B2 (en) * 2006-01-10 2008-01-29 Allergan, Inc. Substituted cyclopentanes or cyclopentanones as therapeutic agents
US7429669B2 (en) * 2006-06-20 2008-09-30 Allergan, Inc. Therapeutic compounds

Similar Documents

Publication Publication Date Title
JP2009541340A5 (OSRAM)
JP2009543795A5 (OSRAM)
JP2009543792A5 (OSRAM)
JP2009543794A5 (OSRAM)
JP2010500976A5 (OSRAM)
JP2010500416A5 (OSRAM)
JP2009535426A5 (OSRAM)
JP5702392B2 (ja) キサンチンオキシダーゼ阻害剤として効果的な新規化合物、その製造方法及びそれを含有する医薬組成物
EP2382212B1 (en) Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
JP2009540009A5 (OSRAM)
JP2010539152A5 (OSRAM)
JP2016515536A5 (OSRAM)
WO2008008660B1 (en) Cyclopentane derivatives as antiglaucoma agents
JP2014530900A5 (OSRAM)
JP2009519965A5 (OSRAM)
JPWO2012102255A1 (ja) インドール誘導体、またはその薬理学的に許容される塩
JP2009535307A5 (OSRAM)
WO2008008718B1 (en) Cyclopentane derivatives as antiglaucoma agents
JP2010504286A5 (OSRAM)
WO2007043457A1 (ja) トリアリールカルボン酸誘導体
WO2013187496A1 (ja) 芳香族複素環化合物
RS57406B1 (sr) Derivat 4-alkinil imidazola i lekovi koji ga sadrže kao aktivni sastojak
JP2011500818A5 (OSRAM)
JP2010510232A5 (OSRAM)
WO2008008701B1 (en) Substituted cyclopentane derivatives as therapeutic agents